bg
A

Adaptimmune - ADR (ADAP)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Adaptimmune - ADR (ADAP)

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more

  • USD1.16
  • USD1.18
  • USD1.10
  • USD2.05
  • 12.50%
  • 14M
  • 1.06M
  • 887.09k
  • 286M
  • 0.42
  • -17.20%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.